Integra Lifesciences Holdings (IART) Capital Expenditures Growth (3y) (2012 - 2026)
Integra Lifesciences Holdings (IART) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | 1.81% |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 0.84% |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | 7.57% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 2.15% |
| 10 | Integra Lifesciences Holdings | 1.51 Bn | 1.25 Bn | 216.98 Mn | 2.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.71% |
| Dec 31, 2025 | 5.99% |
| Sep 30, 2025 | 18.30% |
| Jun 30, 2025 | 28.90% |
| Mar 31, 2025 | 45.83% |
| Dec 31, 2024 | 2.57% |
| Sep 30, 2024 | 59.65% |
| Jun 30, 2024 | 64.83% |
| Mar 31, 2024 | 32.32% |
| Dec 31, 2023 | 42.79% |
| Sep 30, 2023 | 24.81% |
| Jun 30, 2023 | 29.15% |
| Mar 31, 2023 | -6.04% |
| Dec 31, 2022 | -13.32% |
| Sep 30, 2022 | -12.34% |
| Jun 30, 2022 | -18.94% |
| Mar 31, 2022 | -16.62% |
| Dec 31, 2021 | 2.21% |
| Sep 30, 2021 | -24.11% |
| Jun 30, 2021 | -30.78% |